Tonix Pharmaceuticals Holding Corp. [TNXP] has traded in a range of $0.39 to $2.46 in the last 1 year. As of this writing, the stock is at $0.58, up 1.11%. To check whether the stock’s short-term amount has a thrust, its good to check stock’s recent movement. Over the last week, TNXP shares are 1.58% up with the monthly amount drift of -10.73% and seems bad in a long time frame.

On 19, November 2020, Sidoti Virtual Microcap Investor Conference. According to news published on Yahoo Finance, Presentation Times and Weblinks Released for Over 60 Presenting Companies.

Analyst Birdseye View:

The most recent analyst activity for Tonix Pharmaceuticals Holding Corp. [NASDAQ:TNXP] stock was on August 18, 2017, when it was Upgrade with a Buy rating from ROTH Capital, which also raised its 12-month price target on the stock to $6. Before that, on April 18, 2019, ROTH Capital Recapitulated a Buy rating and elevated its amount target to $4. On September 07, 2016, ROTH Capital Downgrade a Neutral rating. On February 17, 2016, Oppenheimer Reiterated an Outperform rating and decreased its price target from $18 to $10. On November 04, 2015, Cantor Fitzgerald Initiated a Buy rating. On June 12, 2015, Oppenheimer Initiated an Outperform rating and boosted its amount on this stock to $18. On February 17, 2015, ROTH Capital Reiterated a Buy rating and boosted its target amount on this stock from $10 to $12. On September 29, 2014, ROTH Capital Reiterated a Buy rating and amplified its amount target to $10.

In the past 52 weeks of trading, this stock has oscillated between a low of $0.39 and a peak of $2.46. Right now, the middling Wall Street analyst 12-month amount mark is $3.00. At the most recent market close, shares of Tonix Pharmaceuticals Holding Corp. [NASDAQ:TNXP] were valued at $0.58.

FUNDAMENTAL ANALYSIS

If looking now at the Principal structure of this organization, it shows its whole liability to the whole Principal at 3.66 and the whole liability to whole assets at 2.46. It shows enduring liability to the whole principal at 0.06 and enduring liability to assets at 0.00 while looking for an extended time period.

Readers are usually of view to make a close observation to the indicators that support and make resistance before moving to any particular stock. As of now, the company’s stock is sitting at 0.5659 points at 1st support level, the second support level is making up to 0.5479. But as of 1st resistance point, this stock is sitting at 0.5959 and at 0.6079 for 2nd resistance point.

Tonix Pharmaceuticals Holding Corp. [TNXP] reported its earnings at -$0.09 per share in the fiscal quarter closing of 9/29/2020. The Analysts for Wall Street were expecting to report its earnings at -$0.11/share signifying the difference of 0.02 and 18.20% surprise value. Comparing the previous quarter ending of 6/29/2020, the stated earnings were -$0.23 calling estimates for -$0.22/share with the difference of -0.01 depicting the surprise of -4.50%.

Important Ratio’s To Watch

Meanwhile, turning our focus to liquidity, the Current Ratio for Tonix Pharmaceuticals Holding Corp. [NASDAQ:TNXP] is 14.20. Likewise, the Quick ratio is also the same, showing Cash ratio at 2.19. Now if looking for a valuation of this stock’s amount to book ratio is 1.06.

Insider Stories

The most recent insider trade was by Treco James, Director, and it was the purchase of 5500.0 shares on Aug 31. Bell Margaret Smith, the Director, completed a purchase of 5391.0 shares on Aug 20. On Aug 17, SULLIVAN GREGORY M, Chief Medical Officer, completed a purchase of 20000.0 shares.